OncoSec Medical (ONCSQ) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock ONCSQ vs. AMPE, CLVR, EFTR, HSTO, PXMD, ATNFW, LBPSW, AEHAW, AIMDW, and ALVOWShould you be buying OncoSec Medical stock or one of its competitors? The main competitors of OncoSec Medical include Ampio Pharmaceuticals (AMPE), Clever Leaves (CLVR), eFFECTOR Therapeutics (EFTR), Histogen (HSTO), PaxMedica (PXMD), 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), and Alvotech (ALVOW). These companies are all part of the "pharmaceutical products" industry. OncoSec Medical vs. Its Competitors Ampio Pharmaceuticals Clever Leaves eFFECTOR Therapeutics Histogen PaxMedica 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Ampio Pharmaceuticals (NYSE:AMPE) and OncoSec Medical (NASDAQ:ONCSQ) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, risk and dividends. Which has more volatility & risk, AMPE or ONCSQ? Ampio Pharmaceuticals has a beta of 4.76, indicating that its stock price is 376% more volatile than the S&P 500. Comparatively, OncoSec Medical has a beta of -19.7, indicating that its stock price is 2,070% less volatile than the S&P 500. Which has stronger earnings and valuation, AMPE or ONCSQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAmpio PharmaceuticalsN/AN/A-$8.63M-$11.01N/AOncoSec MedicalN/AN/A-$34.18MN/AN/A Does the media favor AMPE or ONCSQ? In the previous week, Ampio Pharmaceuticals' average media sentiment score of 0.00 equaled OncoSec Medical'saverage media sentiment score. Company Overall Sentiment Ampio Pharmaceuticals Neutral OncoSec Medical Neutral Do institutionals & insiders have more ownership in AMPE or ONCSQ? 5.7% of Ampio Pharmaceuticals shares are owned by institutional investors. 3.3% of Ampio Pharmaceuticals shares are owned by company insiders. Comparatively, 1.3% of OncoSec Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Is AMPE or ONCSQ more profitable? Company Net Margins Return on Equity Return on Assets Ampio PharmaceuticalsN/A N/A N/A OncoSec Medical N/A N/A N/A SummaryAmpio Pharmaceuticals beats OncoSec Medical on 4 of the 4 factors compared between the two stocks. Get OncoSec Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCSQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ONCSQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ONCSQ vs. The Competition Export to ExcelMetricOncoSec MedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$812.97M$5.55B$9.04BDividend YieldN/A4.84%5.22%4.00%P/E RatioN/A1.3727.6420.24Price / SalesN/A228.55418.75118.07Price / CashN/A23.4436.8958.10Price / BookN/A6.328.035.67Net Income-$34.18M-$27.99M$3.18B$249.21M OncoSec Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ONCSQOncoSec MedicalN/AN/AN/AN/A$1KN/A0.0040AMPEAmpio Pharmaceuticals0.0529 of 5 stars$0.00flatN/AN/A$3KN/A0.0020Gap DownCLVRClever LeavesN/A$0.00flatN/AN/A$1K$17.42M0.00560EFTReFFECTOR TherapeuticsN/A$0.00flatN/A-99.8%$1K$3.55M0.0010HSTOHistogenN/A$0.00-25.0%N/A-99.9%$1K$19K0.0020Gap DownPXMDPaxMedicaN/AN/AN/AN/A$1KN/A0.002ATNFW180 Life SciencesN/A$0.01-6.0%N/A-6.9%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01flatN/A-80.9%$0.00N/A0.002AIMDWAinosN/A$0.18+6.1%N/AN/A$0.00$106.21K0.0040Gap DownALVOWAlvotechN/A$1.73+1.8%N/A-41.9%$0.00$585.60M0.004Positive News Related Companies and Tools Related Companies Ampio Pharmaceuticals Alternatives Clever Leaves Alternatives eFFECTOR Therapeutics Alternatives Histogen Alternatives PaxMedica Alternatives 180 Life Sciences Alternatives 4D pharma Alternatives Aesther Healthcare Acquisition Alternatives Ainos Alternatives Alvotech Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ONCSQ) was last updated on 7/6/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (July 4th Special)Imagine getting a 140% dividend from your investments. Even better? It works with big names like Tesla, ...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSec Medical Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share OncoSec Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONCSQ Stock Alerts